

Prof. Prokar Dasgupta OBE
King’s Health Partners Foundation Professor of Surgery, Chair in Robotic Surgery and Urological Innovation, Chairman King’s-Vattikuti Institute of Robotic Surgery, 10th Editor in Chief, British Journal of Urology International (BJUI)
Surgeon, Clinician-Scientist, Professor, Researcher, Editor-in-Chief
Prokar Dasgupta is a surgeon, clinician-scientist, and academic specialising in urology and robotic surgery. Since 2002, he has served as consultant urologist at Guy’s Hospital. In 2009, he became the first professor of robotic surgery and urology at King’s College London and subsequently chairman of the King’s College-Vattikuti Institute of Robotic Surgery. In 2020, he was appointed foundation professor of surgery at King’s Health Partners, an academic health science centre in London.
His early research addressed the immunology of Leishmaniasis and later focused on urological conditions such as overactive bladder (OAB) and prostate cancer. While at the National Hospital for Neurology and Neurosurgery, Queen Square, he developed, alongside Clare Fowler, a method to inject botulinum toxin (Botox) into the bladder wall using a flexible cystoscope to treat urinary incontinence caused by OAB. This technique, known as the "Dasgupta technique," was the first of its kind in the UK and became included in National Institute for Health and Care Excellence (NICE) guidelines in 2006 as a second-line treatment.
Dasgupta led the first use of a da Vinci robotic system in the UK for kidney transplant surgery in 2005. He also pioneered the use of 3D-printed prostate models to assist in robotic prostate cancer surgery, first applied in 2015.
He has been a trustee of prostate cancer charities, including The Malcolm Coptcoat Trust and the Prostate Cancer Research Centre at King’s College London, where he also chairs the research centre.
Between 2013 and 2020, he was editor-in-chief of the British Journal of Urology International (BJUI).
Dasgupta has authored and co-authored over 1,100 articles, including more than 600 peer-reviewed papers, ten books, and 25 book chapters. His research funding has exceeded £40 million from agencies including the Medical Research Council, Wellcome Trust, and Engineering and Physical Sciences Research Council.
He developed the world’s first laparoscopic nephrectomy simulator and has led projects on robotic surgical training and simulation for patient safety.
He has served on committees for the British Association of Urological Surgeons (BAUS), including council, trusteeship, specialist advisory committees, and examination boards. He is a member of the NICE Guidelines Panel and a founding member of the European Association of Urology Robotics Section.
Awards include the Karl Storz Harold Hopkins Golden Telescope Award (2006), Fellowship of the Linnaean Society (2017), Fellowship of King’s College (2018), the St Peter’s Medal from BAUS (2020), Kings James IV Professorship of Surgery from the Royal College of Surgeons of Edinburgh (2021), and the Padma Shri awarded by the Government of India (2022). He was appointed Officer of the Order of the British Empire (OBE) in the 2023 Birthday Honours for services to surgery and science.
Dasgupta has been involved in the clinical direction of the MedTech Hub at St Thomas’ Hospital with a budget of £110 million and is a mentor to the National Clinical Entrepreneurship Programme.
He has contributed to and guided surgical services during the COVID-19 pandemic through international correspondence and blogs.